食管鳞状细胞癌(ESCC)是一种常见的消化道恶性肿瘤,具有侵袭性强、预后差等特点。传统治疗方法(手术、放疗、化疗)的效果有限,总体生存率仍不令人满意。近年来,免疫检查点抑制剂(ICI)在多种癌症中展现出显著疗效,成为治疗领域的一大突破。但由于不同患者对ICI反应存在较大差异,部分患者可获得长期生存,而另一部分则收效甚微。因此,寻找可靠的预测性生物标志物,以指导患者选择和优化治疗方案,尤为关键。
As cells are infected by microorganisms, they can pre-emptively die to prevent the replication and spreading of the pathogen. Cell death that is associated with the presence of pathogen-associated ...
近日,中国科学技术大学生物医学工程学院王育才教授课题组通过体内筛选优化得到的低免疫原性LNPs,成功在体内直接编程生成耐受性抗原呈递细胞(tol-APCs),治疗自身免疫性疾病(AIDs)。相关研究成果以“Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 ...
IL-4 and IL-13 promote binding of costimulatory molecules (CD40 with CD40 ligands and CD80 or CD86 with CD28) on Th2 cells and B cells, thereby leading to differentiation of B cells into plasma ...
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果